Eden Research (LON:EDEN) Trading Down 4.7% – Here’s What Happened

Shares of Eden Research plc (LON:EDEN) traded down 4.7% on Friday . The stock traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.43 ($0.04). 291,737 shares were traded during mid-day trading, a decline of 69% from the average session volume of 928,598 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Stock Down 4.7 %

The company has a market capitalization of £18.29 million, a PE ratio of -12.02 and a beta of 0.92. The company has a current ratio of 3.80, a quick ratio of 2.42 and a debt-to-equity ratio of 1.26. The firm has a 50 day simple moving average of GBX 3.88 and a two-hundred day simple moving average of GBX 3.95.

Insider Activity at Eden Research

In other news, insider Alexander John Abrey purchased 540,540 shares of the business’s stock in a transaction that occurred on Tuesday, January 28th. The stock was purchased at an average cost of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($27,396.86). Also, insider Lykele van der Broek acquired 256,000 shares of the stock in a transaction on Thursday, February 6th. The stock was acquired at an average cost of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($12,975.16). 14.02% of the stock is currently owned by insiders.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.